{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:20:10Z","timestamp":1793974810752,"version":"4.8.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13104-017-2679-5","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T08:10:10Z","timestamp":1501143010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clozapine-induced, dilated cardiomyopathy: a case report"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9956-353X","authenticated-orcid":false,"given":"Sarah","family":"Longhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Heres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"2679_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2014.07.103","volume":"176","author":"M Alawami","year":"2014","unstructured":"Alawami M, Wasywich C, Cicovic A, Kenedi C. A systematic review of clozapine induced cardiomyopathy. Int J Cardiol. 2014;176:315\u201320.","journal-title":"Int J Cardiol"},{"key":"2679_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","volume":"329","author":"JMJ Alvir","year":"1993","unstructured":"Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis\u2013incidence and risk factors in the United States. N Engl J Med. 1993;329:162\u20137.","journal-title":"N Engl J Med"},{"key":"2679_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/cap.2010.2062","volume":"20","author":"VT Bobb","year":"2010","unstructured":"Bobb VT, Jarskog LF, Coffey BJ. Adolescent with treatment-refractory schizophrenia and clozapine-induced cardiomyopathy managed with high-dose olanzapine. J Child Adolesc Psychopharmacol. 2010;20:539\u201343.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2679_CR4","unstructured":"Fontana PG, S\u00fcmegi B. Association of Clozaril (clozapine) with cardiovascular toxicity. Novartis Pharmaceuticals Canada Inc. 2002."},{"key":"2679_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00002018-200730010-00005","volume":"30","author":"SJ Haas","year":"2007","unstructured":"Haas SJ, Hill R, Krum H, Liew D, Tonkin A, Demos L, Stephan K, McNeil J. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993\u20132003. Drug Saf. 2007;30:47\u201357.","journal-title":"Drug Saf"},{"key":"2679_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.schres.2004.05.015","volume":"73","author":"J Hennen","year":"2005","unstructured":"Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res. 2005;73:139\u201345.","journal-title":"Schizophr Res"},{"key":"2679_CR7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(75)90206-8","volume":"2","author":"J Idanpaan-Heikkila","year":"1975","unstructured":"Idanpaan-Heikkila J, Alhava E, Olkinuora M, Palva I. Letter: clozapine and agranulocytosis. Lancet. 1975;2:611.","journal-title":"Lancet"},{"key":"2679_CR8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","volume":"354","author":"JG Kilian","year":"1999","unstructured":"Kilian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999;354:1841\u20135.","journal-title":"Lancet"},{"key":"2679_CR9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","volume":"63","author":"MI Krakowski","year":"2006","unstructured":"Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2006;63:622\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"2679_CR10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lassig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382:951\u201362.","journal-title":"Lancet"},{"key":"2679_CR11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","volume":"32","author":"SW Lewis","year":"2006","unstructured":"Lewis SW, Barnes TRE, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull. 2006;32:715\u201323.","journal-title":"Schizophr Bull"},{"key":"2679_CR12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","volume":"74","author":"J Nielsen","year":"2013","unstructured":"Nielsen J, Correll CU, Manu P, Kane JM. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided? J Clin Psychiatry. 2013;74:603\u201313 (quiz 613).","journal-title":"J Clin Psychiatry"},{"key":"2679_CR13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/00048674.2011.572852","volume":"45","author":"KJ Ronaldson","year":"2011","unstructured":"Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust NZ J Psychiatry. 2011;45:458\u201365.","journal-title":"Aust NZ J Psychiatry"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2679-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T08:10:32Z","timestamp":1501143032000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-2679-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2679"],"URL":"https:\/\/doi.org\/10.1186\/s13104-017-2679-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"article-number":"338"}}